Key Clinical Considerations in HIV Treatment Decisions
The panel offers expert perspectives on key factors that inform treatment decisions for patients with HIV.
EP: 1.The Role of the Primary Care Provider/Advanced Practice Provider in HIV Management
EP: 2.Evolving Treatment Practices and Guidelines for HIV
EP: 3.Key Clinical Considerations in HIV Treatment Decisions
EP: 4.HIV Treatment: Discussing Adverse Events with Patients
EP: 5.Importance of Starting HIV Treatment Early
EP: 6.Treatment Resistance in HIV
EP: 7.HIV Drug Resistance Testing Practices and Patient Education
EP: 8.Managing Suboptimal Adherence to HIV Medications
EP: 9.HIV Treatment Clinical Experiences
EP: 10.Addressing Suboptimal Treatment Response in HIV
Video content above is prompted by the following question(s):
1. Three drug regimens have been the mainstay of successful HIV-1 treatment since 1996. Although we have seen improvement in the efficacy, adverse effects, and toxicities of contemporary three-drug regimens, even the newest therapies have potential adverse effects. Two-drug combinations are now part of the treatment guidelines and include the first long-acting antiretroviral regimen for the treatment of HIV-1 suppression. Gibas et al 2022
• Can you discuss two versus three drug regimens? Individualized care
